The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, NeuroOne Medical Technologies's share price is $1.06.
NeuroOne Medical Technologies's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $0.16. Hence, NeuroOne Medical Technologies's PS Ratio for today is 6.50.
Good Sign:
NeuroOne Medical Technologies Corp stock PS Ratio (=6.5) is close to 5-year low of 6.5
The historical rank and industry rank for NeuroOne Medical Technologies's PS Ratio or its related term are showing as below:
NMTC'
s PS Ratio Range Over the Past 10 Years
Min: 6.5 Med: 109.67 Max: 1216.67
Current: 6.5
During the past 13 years, NeuroOne Medical Technologies's highest PS Ratio was 1216.67. The lowest was 6.50. And the median was 109.67.
NMTC's PS Ratio is ranked worse than 71.57% of 809
companies
in the Medical Devices & Instruments industry
Industry Median: 3.28
vs NMTC: 6.50
During the past 13 years, NeuroOne Medical Technologies's highest 3-Year average Revenue per Share Growth Rate was -30.70% per year. The lowest was -30.70% per year. And the median was -30.70% per year.
Back to Basics: PS Ratio
NeuroOne Medical Technologies PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of NeuroOne Medical Technologies's PS Ratio
For the Medical Devices subindustry, NeuroOne Medical Technologies's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NeuroOne Medical Technologies's PS Ratio Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, NeuroOne Medical Technologies's PS Ratio distribution charts can be found below:
* The bar in red indicates where NeuroOne Medical Technologies's PS Ratio falls into.
NeuroOne Medical Technologies PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
NeuroOne Medical Technologies's Share Price of today is $1.06. NeuroOne Medical Technologies's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.16.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
NeuroOne Medical Technologies (NAS:NMTC) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
NeuroOne Medical Technologies PS Ratio Related Terms
Thank you for viewing the detailed overview of NeuroOne Medical Technologies's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
NeuroOne Medical Technologies (NeuroOne Medical Technologies) Business Description
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NMTC has been successfully added to your 